6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias

JACC: Cardiovascular Interventions

Volumn 8, Issue 7, 2015, Pages 984-990

  Armaganijan, Luciana V ^a   Staico, Rodolfo ^a   Moreira, Dalmo A R ^a   Lopes, Renato D ^b,c   Medeiros, Paulo T J ^a   Habib, Ricardo ^a   Melo Neto, Jônatas ^a   Katz, Marcelo ^c   Armaganijan, Dikran ^a   Sousa, Amanda G M R ^a   Mahfoud, Felix ^d,e   Abizaid, Alexandre ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Brazilian Clinical Research Institute   (Brazil)

^d SAARLAND UNIVERSITY   (Germany)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

implantable cardiac defibrillators; renal denervation; sympathetic activity; ventricular arrhythmias

Indexed keywords

ADRENALIN; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BRADYCARDIA; CHAGAS DISEASE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; FEMALE; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; KIDNEY DENERVATION; KIDNEY DISEASE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RENAL SYMPATHETIC DENERVATION; TREATMENT DURATION; TREATMENT OUTCOME; ADVERSE EFFECTS; BRAZIL; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; DEVICES; INNERVATION; KIDNEY; KIDNEY ARTERY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TIME; VASCULARIZATION; VENTRICULAR FIBRILLATION;

AGED; BRAZIL; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY; RISK FACTORS; SYMPATHECTOMY; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84931334179     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.03.012     Document Type: Article

References (31)

1. N. Arenja, B. Schaer, C. Sticherling, and M. Kuhne [Current indications for an implantable cardioverter defibrillator (ICD)] Ther Umsch 71 2014 111 116
2. C. Droogan, C. Patel, G.X. Yan, and P.R. Kowey Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy Heart Fail Clin 7 2011 195 205 viii
3. W. Haverkamp, G. Hindricks, and H. Gulker Antiarrhythmic properties of beta-blockers J Cardiovasc Pharmacol 16 Suppl 5 1990 S29 S32
4. P. Dorian Antiarrhythmic action of beta-blockers: potential mechanisms J Cardiovasc Pharmacol Ther 10 Suppl 1 2005 S15 S22
5. J.S. Bradfield, E. Buch, and K. Shivkumar Interventions to decrease the morbidity and mortality associated with implantable cardioverter-defibrillator shocks Curr Opin Crit Care 18 2012 432 437
6. C. Lavalle, C. Pandozi, and M. Santini [Defibrillator implantation associated with ventricular arrhythmia ablation: an emerging hybrid approach] G Ital Cardiol (Rome) 13 2012 110 117
7. F. Sacher, U.B. Tedrow, and M.E. Field Ventricular tachycardia ablation: evolution of patients and procedures over 8 years Circ Arrhythm Electrophysiol 1 2008 153 161
8. F.H. Leenen Cardiovascular consequences of sympathetic hyperactivity Can J Cardiol 15 Suppl A 1999 2A 7A
9. D. Hering, P. Marusic, and A.S. Walton Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension Hypertension 64 2014 118 124
10. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 2009 932 934
11. H. Krum, M.P. Schlaich, and P.A. Sobotka Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study Lancet 383 2014 622 629
12. I. Sudano, G. Noll, and T.F. Luscher Potential new indications and future studies EuroIntervention 9 Suppl R 2013 R155 R160
13. C. Ukena, F. Mahfoud, D. Linz, M. Bohm, and H.R. Neuberger Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias EuroIntervention 9 Suppl R 2013 R110 R116
14. C. Ukena, A. Bauer, and F. Mahfoud Renal sympathetic denervation for treatment of electrical storm: first-in-man experience Clin Res Cardiol 101 2012 63 67
15. R. Staico, L. Armaganijan, and D. Moreira Renal sympathetic denervation and ventricular arrhythmias: a case of electrical storm with multiple renal arteries EuroIntervention 10 2014 166
16. L. Armaganijan, R. Staico, and A. Moraes Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy? Arq Bras Cardiol 102 2014 355 363
17. M.N. Levy, and H. Zieske Autonomic control of cardiac pacemaker activity and atrioventricular transmission J Appl Physiol 27 1969 465 470
18. D.P. Zipes Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system Cleve Clin J Med 75 Suppl 2 2008 S94 S96
19. D. Linz, C. Ukena, F. Mahfoud, H.R. Neuberger, and M. Bohm Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? J Am Coll Cardiol 63 2014 215 224
20. M. Vaseghi, J. Gima, and C. Kanaan Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up Heart Rhythm 11 2014 360 366
21. B.F. Remo, M. Preminger, and J. Bradfield Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy Heart Rhythm 11 2014 541 546
22. D. Linz, K. Wirth, and C. Ukena Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs Heart Rhythm 10 2013 1525 1530
23. J.R. Coura, and J.C. Dias Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery Mem Inst Oswaldo Cruz 104 Suppl 1 2009 31 40
24. M.C. Nunes, W. Dones, C.A. Morillo, J.J. Encina, A.L. Ribeiro Council on Chagas Disease of the Interamerican Society of Cardiology Chagas disease: an overview of clinical and epidemiological aspects J Am Coll Cardiol 62 2013 767 776
25. M. de Menezes, A. Rocha, A.C. da Silva, and A.M. da Silva [Basic causes of death in elderly patients with Chagas' disease] Arq Bras Cardiol 52 1989 75 78
26. A.A. de Paola, L.N. Horowitz, and M.H. Miyamoto Angiographic and electrophysiologic substrates of ventricular tachycardia in chronic Chagasic myocarditis Am J Cardiol 65 1990 360 363
27. M. Scanavacca, and E. Sosa Catheter ablation to treat sustained ventricular tachycardia in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillator J Am Coll Cardiol 63 2014 1028 1029
28. J.P. Andrade, J.A. Marin-Neto, and A.A. Paola [I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy] Arq Bras Cardiol 97 2011 1 48
29. J.P. Piccini, J.S. Berger, and C.M. O'Connor Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur Heart J 30 2009 1245 1253
30. M. Martinelli Filho, S.F. De Siqueira, and H. Moreira Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease Pacing Clin Electrophysiol 23 2000 1944 1946
31. A.V. Sarabanda, E. Sosa, M.V. Simoes, G.L. Figueiredo, A.O. Pintya, and J.A. Marin-Neto Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms Int J Cardiol 102 2005 9 19